John Rountree was asked by Die Zeit to reflect on the recent merger that threatens to split apart the German giant, Bayer:

The crisis at Bayer definitely has “grave consequences for the reputation of the company and the management, however they could possibly drive the group into a split: pharmaceuticals and agriculture. If the company is financially weakened, activist investors could appear and press for a sale of the profitable parts. This is how it has often happened in the world of large corporations.”

This is not the first time John has been asked for his view on the merger, having spoken on CNBC in 2016 and 2017 and airing his views this year for Bloomberg.

View the full article in German or English, alternatively for our views on M&A click here.


To receive details of new white papers and events please enter your details below

Click here if you would like to receive emails from us. Read our privacy policy

Newsletter Signup